(HealthDay)—There are patient characteristics and clinical factors independently associated with physical and mental quality of life (QOL) in patients with head and neck cancer undergoing radiotherapy, according to a study ...
Aug 11, 2017
0
1
(HealthDay)—A novel rehabilitative swallowing exercise program aids long-term head and neck cancer survivors with chronic dysphagia, according to a study published online Aug. 2 in Head & Neck.
Aug 10, 2017
0
2
(HealthDay)—A high-observation protocol (HOP) appears to optimize clinical care for patients with head and neck cancer undergoing primary surgery, according to a study published online June 20 in Head & Neck.
Jul 7, 2017
0
0
(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.
Jun 27, 2017
0
0
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...
May 7, 2017
0
1
New research suggests that some patients with head and neck cancers can benefit by continuing treatment with an immunotherapy drug after their tumors show signs of enlargement according to investigators at Dana-Farber Cancer ...
Apr 3, 2017
0
0
Researchers at the University of Cincinnati (UC) have discovered that an ion channel, active within T cells (white blood cells), could be targeted to reduce the growth of head and neck cancers.
Nov 17, 2016
0
46
Incidence of head and neck cancers - usually defined as malignancies above the collarbone but outside the brain - are on the rise, according to statistics from the American Cancer Society (ACS). The most common is thyroid ...
Aug 1, 2016
0
6
Potent doses of broccoli sprout extract activate a "detoxification" gene and may help prevent cancer recurrence in survivors of head and neck cancer, according to a trial by the University of Pittsburgh Cancer Institute, ...
Jun 23, 2016
0
16
The immunotherapy drug nivolumab has become the first to show a survival benefit in head and neck cancer, after a major international trial found that it was more effective than standard chemotherapy.
Apr 19, 2016
0
21
